An AI method offers a new way to understand protein structures in multiple dimensions and may be a useful tool for ...
A “can-do” attitude toward monoclonal antibody (mAb) production developed over the last 30 years has set the groundwork for ...
The elements needed to automate cell and gene therapy production are already available, they just need to be combined.
Lonza's new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
Synthego announced that it will focus solely on the therapeutic applications of CRISPR while spinning off a new company, ...
Research from scientists at Albert Einstein College of Medicine, Northwestern University, and elsewhere indicates that forming long-term memories requires DNA damage and brain inflammation. The ...
A study conducted in mice by researchers in the lab of Irvine Weissman, MD, at Stanford University School of Medicine, and at the National Institutes of Health’s Rocky Mountain Laboratories, has ...
A new potential target for Alzheimer's disease has been identified by researchers at the University of Leeds and Lancaster University. Their study in mice demonstrated that reducing the activity of ...
In January, the FDA published, “Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products: Guidance for Industry.” To find out how this guidance impacts the CAR-T industry, ...
Step toward an HIV cure: a "shock and kill" virus-like particle shows promise as latency reversal agent in blood samples from ...
Researchers have created an AI model to design antibiotics that inhibit the growth of Acinetobacter baumannii, a common ...
The FDA has authorized Invivyd's Pemgarda™ (pemivibart), indicated for prevention of COVID-19 in adults and adolescents ages 12 and older.